• Terms and Conditions
  • Privacy Policy
  • DMCA
  • Disclaimer
  • Cookie Privacy Policy
  • Contact Us
Sixsense News
Advertisement
  • Home
  • Business
  • Economy
  • Fintech
  • Finance
  • Insurance
  • Market
  • Startups
No Result
View All Result
  • Home
  • Business
  • Economy
  • Fintech
  • Finance
  • Insurance
  • Market
  • Startups
No Result
View All Result
Sixsense News
No Result
View All Result
Home Market

Myovant stock trades above $22.75/share as analyst see likely higher bid (NYSE:MYOV)

Sixsense News by Sixsense News
October 3, 2022
in Market
0


Maksim Labkouski

Myovant Sciences (NYSE:MYOV) jumped 32% and traded above Sumitovant Biopharma’s $22.75/share offer as analysts see the potential for an increased bid and possible interest from partner Pfizer (PFE).

“In our view, we think Sumitovant’s offer appears somewhat opportunistic, and bullish investors may be able to argue that Myovant could sell for a premium to the initial $22.75/share offer,” SVB Leerink analyst Roanna Ruiz, who has an outperform rating and $23 price target on MYOV wrote in a note on Monday.

Myovant (MYOV) disclosed Sunday that a special committee of its board rejected a $2.4 billion, or $22.75/share, offer from Sumitovant Biopharma to buy the remaining shares of the biopharma company it doesn’t already own. Sumitovant currently holds approximately 52% of the outstanding shares of Myovant (MYOV). The offer represents a 27% premium to MYOV’s closing price on Friday.

Myovant (MYOV) may be in a good position to negotiate a better deal due to multiple potential “value drivers” over the next year including recent approval of Myfembree in its 2nd women’s health indication of endometriosis and continued strong US launch momentum for Orgovyx in advanced prostate cancer, according to Baird’s Ruiz.

Baird also sees a potential increased bid at an acquisition price in the high $20s, analyst Brian Skorney wrote in a note on Monday. Baird has an outperform rating and $20 price target for Myovant (MYOV).

“This is balanced by the acknowledgment that, as the majority shareholder, Sumitomo is also in a strong bargaining position, although Pfizer could also be a potentially interested party, given the collaboration on Orgovyx,” Skorney wrote.

Sumitovant said in a statement Sunday that it has no interest in selling any of the Myovant shares it owns, nor would Sumitovant support any alternative sale, merger, or similar transaction involving Myovant (MYOV).



Source link

Related articles

Petrofac, Hitachi Energy win €13B deal to expand offshore wind capacity (OTCMKTS:POFCF)

March 30, 2023

Streaming device maker Roku to cut 200 jobs in second round of layoffs By Reuters

March 30, 2023
Tags: 22.75shareanalystbidhigherMyovantNYSEMYOVstocktrades

Related Posts

Petrofac, Hitachi Energy win €13B deal to expand offshore wind capacity (OTCMKTS:POFCF)

by Sixsense News
March 30, 2023
0

Klaus Vedfelt Petrofac (OTCPK:POFCF) (OTCPK:POFCY) and Hitachi Energy (OTCPK:HTHIY) (OTCPK:HTHIF) said Thursday they were awarded a multiyear agreement worth ~€13B...

Streaming device maker Roku to cut 200 jobs in second round of layoffs By Reuters

by Reuters
March 30, 2023
0

© Reuters. FILE PHOTO A video sign displays the logo for Roku Inc, a Fox-backed video streaming firm, in Times...

Set of 5 Exercise Workout Bands only $10.32!

by Gretchen
March 30, 2023
0

Home » Deals » Set of 5 Exercise Workout Bands only $10.32! Published: by Gretchen on March 30, 2023  |  This post...

9 Grocery Shopping Mistakes That Will Cost You

by Brandon Ballenger
March 30, 2023
0

Kattecat / Shutterstock.com Many people don’t think of groceries as a “bill,” but buying them can be one of a...

Ahead of Market: 10 things that will decide stock action on Friday

by Sixsense News
March 30, 2023
0

Domestic stock indices amid positive global cues ended Wednesday’s session on a positive note led by momentum in Adani Group...

Load More

U.S. has millions of missing workers—not because of COVID

March 30, 2023

Does the Insurer in California Have Any Liability When It Suggests or Recommends a Contractor for the Repair Work? | Property Insurance Coverage Law Blog

March 30, 2023

Swiss authorities reveal cost of Credit Suisse’s liquidity lifeline By Reuters

March 30, 2023

Petrofac, Hitachi Energy win €13B deal to expand offshore wind capacity (OTCMKTS:POFCF)

March 30, 2023

Evercore ISI upgrades says it’s time to buy WMT on improving traffic trends

March 30, 2023

Futures rise ahead of key inflation data as bank fears ebb By Reuters

March 30, 2023
Sixsense News

© 2022 Sixsense News All Rights Reserved.

Navigate Site

  • Terms and Conditions
  • Privacy Policy
  • DMCA
  • Disclaimer
  • Cookie Privacy Policy
  • Contact Us

Follow Us

No Result
View All Result
  • #3158 (no title)
  • Business
  • Economy
  • Finance
  • Fintech
  • Insurance
  • Market
  • Startups

© 2022 Sixsense News All Rights Reserved.